As per DelveInsight analysis in the intracranial aneurysms market, the increase in the number of cases associated with abnormalities in the blood vessels present in the brain such as aneurysms, arteriovenous malformations (AVMs) because of the rise in sedentary lifestyle among the population across the globe and approval & launch of various intracranial aneurysm treatment devices are the factors likely to propel the market of intracranial aneurysms.
DelveInsight’s Intracranial Aneurysms Market Insights report provides the current and forecast market, forthcoming device innovation, individual leading companies market shares, challenges, intracranial aneurysms market drivers, barriers, and trends, and key intracranial aneurysms companies in the market.
Intracranial Aneurysms
An intracranial aneurysm or a cerebral aneurysm is an abnormal focal dilation of a brain artery due to the weakening the inner muscular layer of a blood vessel wall. The vessel develops a “blister-like” dilation that can become thin and rupture without warning. The treatment for intracranial aneurysms mainly includes two options: the surgical clipping, and the other, which is less invasive than surgical clipping, is the endovascular treatment approach involving devices such as a flow diverter an intraluminal flow disrupter, a stent, or coils.
Intracranial Aneurysms Market Insights
Geographically, the global intracranial aneurysms market is studied in North America, Europe, Asia-Pacific, and the Rest of the World. In terms of revenue share, North America currently leads the global intracranial aneurysms market and is projected to hold its market position during the study period. This domination is because of the exponentially rising prevalence of the target population in the region.
In addition, the strategic business activities and approval of products in the region for the expansion of the intracranial aneurysm market would also boost the regional market. Thus, the increase in the number of aneurysm cases and expansion of the intracranial aneurysms treatment devices market in the region is expected to increase the intracranial aneurysms market.
To know more about why North America is leading the market growth in the intracranial aneurysms market, get a snapshot of the report Intracranial Aneurysms Market
Recent Developments in the Intracranial Aneurysms Market Report
- In October 2020, Shanghai MicroPort NeuroTech Co., Ltd. (“MicroPort® NeuroTech”) received the registration certificates issued by China’s National Medical Products Administration (NMPA) for its proprietary NUMEN Coil Embolization System and NUMEN FR Coil Detachment System for the treatment of cerebral aneurysms through minimally invasive neurovascular intervention.
- In April 2020, phenox GmbH launched p64 MW Flow Modulation Device with HPC coating technology to treat intracranial aneurysms in the European market. The device received the CE mark in January 2020.
- Thus, owing to such developments in the market, rapid growth will be observed in the intracranial aneurysms market during the forecast period.
To read more about the latest highlights related to intracranial aneurysms, get a snapshot of the key highlights entailed in the Intracranial Aneurysms Market Landscape
Key Players in the Intracranial Aneurysms Market
The leading intracranial aneurysms companies with the best hysteroscopy medical devices such as Medtronic, MicroPort Scientific Corporation., B. Braun Melsungen AG, Stryker, Johnson & Johnson Services, Inc., Terumo Corporation, Penumbra, Inc., Balt, Wallaby Medical., Shape Memory Medical Inc., Zylox-Tonbridge Medical Technology Co., Ltd., Spartan Micro, Inc., Mizuho Medical Co.Ltd., Lepu Medical Technology(Beijing)Co., Ltd., Phenox GmbH, Peter LAZIC GmbH, adeor medical AG., Boston Scientific Corporation, Meril Life Sciences Pvt. Ltd., KANEKA CORPORATION, and others are currently working in the intracranial aneurysms Market.
COVID-19 Impact Analysis on the Intracranial Aneurysms Market
The global intracranial aneurysms market is projected to witness considerable growth owing to the rise in approval and launch of various technologically advanced intracranial aneurysm treatment products. Also, the rising research and development activities for developing intracranial aneurysm treatment devices, and the growing burden of the old-age population, worldwide are contributing to the intracranial aneurysm market.
Moreover, the COVID-19 pandemic has seriously affected the worldwide healthcare system. The system was transitioned at very short notice to deal with the burden of the pandemic, meaning that other health issues were unavoidably side-lined. Moreover, the implementation of lockdown, social distancing norms, containment measures in several countries, and a halt in various surgeries have slowed down the intracranial aneurysms market.
Scope of the Intracranial Aneurysms Market Report
- Coverage: Global
- Study Period: 2019–2027
- Market Segmentation By Product Type: Surgical Clipping, Embolization Coils, Flow Diverters, Others
- Market Segmentation By End User: Hospitals and Ambulatory Surgical Centers
- Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of World
- Key Intracranial Aneurysms Companies: Medtronic (NYSE: MDT), MicroPort Scientific Corporation., B. Braun Melsungen AG, Stryker (NYSE: SYK), Johnson & Johnson Services, Inc. (NYSE: JNJ), Terumo Corporation (OTCMKTS: TRUMY), Penumbra, Inc. (NYSE: PEN), Balt, Wallaby Medical., Shape Memory Medical Inc., Zylox-Tonbridge Medical Technology Co., Ltd., Spartan Micro, Inc., Mizuho Medical Co.Ltd., Lepu Medical Technology (Beijing)Co., Ltd., Phenox GmbH, Peter LAZIC GmbH, adeor medical AG., Boston Scientific Corporation (NYSE: BSX), Meril Life Sciences Pvt. Ltd., KANEKA CORPORATION, among others
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
DelveInsight Analysis: The intracranial aneurysms market size is expected to grow at a CAGR of 9.10% to reach about USD 1.90 billion by 2027.
Which MedTech key players in the intracranial aneurysms market are set to emerge as the trendsetter explore @ Intracranial Aneurysms Companies
Table of Contents
| 1 | Intracranial Aneurysms Market Report Introduction |
| 2 | Intracranial Aneurysms Market Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Intracranial Aneurysms Market Key Factors Analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Intracranial Aneurysms Market |
| 7 | Intracranial Aneurysms Market Layout |
| 8 | Global Company Share Analysis – Key 3-5 Companies |
| 9 | Company and Product Profiles |
| 10 | Project Approach |
| 11. | About DelveInsight |
Interested in knowing how the Intracranial Aneurysms Market will be growing by 2027? Click to get a snapshot of the Intracranial Aneurysms Market Analysis
Related Reports
Brain Aneurysm Stents Market Insights, Competitive Landscape, and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key brain aneurysm stents including Phenox GmbH, Peter LAZIC GmbH, adeor medical AG., Boston Scientific Corporation, among others.
Peripheral Aneurysm Market Insights, Competitive Landscape and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key peripheral aneurysms including Medtronic, Abbott, Stryker, among others.
Aortic Aneurysm Stent Grafts Market
Aortic Aneurysm Stent Grafts Market Insights, Competitive Landscape and Market Forecast – 2027 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key aortic aneurysm stent grafts including Medtronic, Terumo, Shanghai MicroPort Endovascular MedTech, among others.
Abdominal Aortic Aneurysm Market
Abdominal Aortic Aneurysm Market Insights, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key abdominal aortic aneurysm including Endologix LLC, Cardinal Health, Cook Medical, among others.
Aneurysmal Subarachnoid Hemorrhage Market
Aneurysmal Subarachnoid Hemorrhage Market Insights, Epidemiology and Market Forecast – 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key aneurysmal subarachnoid hemorrhage including Idorsia Pharmaceuticals, BIT Pharma GmbH, Akari Therapeutics, among others.
Other Trending Reports
Frontotemporal Dementia Market | Follicular Lymphoma Market | Diabetes Market | Blastic Plasmacytoid Dendritic Cell Neoplasm Market | Bevacizumab Biosimilars Insight | Bacterial Conjunctivitis Market | FENEBRUTINIB Market | Peripherally Inserted Central Catheter Devices Market | Cardiac Biomarkers Testing Devices Market | Epstein Barr virus Market | Hay Fever Conjunctivitis Market | Advanced Wound Care Market | Adeno-Associated Virus Vectors in Gene Therapy Market | Acute Respiratory Distress Syndrome Market | Primary Immune Deficiency Market
Trending Healthcare Blogs
- CRISPR Technology Market
- Pulmonary Arterial Hypertension Treatment Scenario
- At Home Medical Devices
- Epidiolex vs. Fintepla
- Diabetic Retinopathy Market
- Outbreak of Monkeypox
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Us
Shruti Thakur
info@delveinsight.com
+1(919)321-6187